NantHealth has validated successful DeviceConX™ integration with Baxter’s Prismaflex system, used to treat critically-ill patients in the ICU Connectivity is being used in multiple U.S. hospitals ...
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S. Food and Drug ...
“We are doing whatever it takes to support healthcare providers as they care for patients during extraordinary circumstances. Oxiris offers a new tool in the COVID-19 fight while supplementing our ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
* BAXTER INTERNATIONAL INC - HAS BOOSTED ITS CAPACITY AND PRODUCTION TO HELP ADDRESS HIGHER DEMAND FOR PRODUCTS INCLUDING PRISMAX AND PRISMAFLEX * BAXTER INTERNATIONAL - SINCE EMERGENCE OF COVID-19, ...
Oxiris Blood Purification Filter is intended for the use in critically ill COVID19 patients in need of blood purification where excessive inflammatory mediators are present i.e. cytokine storm release ...
(Reuters) -Medical supplies provider Baxter International Inc has approached medication management software vendor Omnicell Inc with an offer to acquire it for more than $5 billion, people familiar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback